Medicare Enrolled

Dr. Robert Ordonez, M.D.

Family Medicine · Lubbock, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
3709 22ND PL, Lubbock, TX 79410
8067972616
In practice since 2006 (19 years)
NPI: 1740375880 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ordonez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ordonez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ordonez

Dr. Robert Ordonez is a family medicine in Lubbock, TX, with 19 years in practice. Based on federal Medicare data, Dr. Ordonez performed 969 Medicare services across 544 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ordonez received a total of $18,689 from 56 pharmaceutical and/or device companies across 678 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ordonez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 29% volume in TX$ $18,689 industry payments

Medicare Practice Summary

Medicare Utilization ↗
969
Medicare services
Top 29% in TX for family medicine
544
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~51 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)603$81$231
Annual wellness visit, follow-up168$124$379
Electrocardiogram (EKG), 12-lead87$10$80
Office visit, established patient (20-29 min)76$63$216
Office visit, established patient, complex (40-54 min)35$111$337
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$18,689
Total received (2018-2024)
Avg $2,670/year across 7 years
Top 1% in TX for family medicine
56
Companies
678
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,801 (63.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,790 (36.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$98 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,372
2023
$7,487
2022
$1,254
2021
$2,339
2020
$2,176
2019
$1,933
2018
$2,127

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$7,038
Amgen Inc.
$1,159
Lilly USA, LLC
$1,089
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$993
ABBVIE INC.
$799
Novartis Pharmaceuticals Corporation
$694
Novo Nordisk Inc
$670
AstraZeneca Pharmaceuticals LP
$462
AbbVie Inc.
$448
Amarin Pharma Inc.
$373
Radius Health, Inc.
$315
SANOFI-AVENTIS U.S. LLC
$312
Takeda Pharmaceuticals U.S.A., Inc.
$311
PFIZER INC.
$302
ARBOR PHARMACEUTICALS, INC.
$287
Arbor Pharmaceuticals, Inc.
$246
Allergan, Inc.
$245
Allergan Inc.
$211
Abbott Laboratories
$207
Daiichi Sankyo Inc.
$205
Astellas Pharma US Inc
$188
GlaxoSmithKline, LLC.
$150
Boehringer Ingelheim Pharmaceuticals, Inc.
$149
Janssen Pharmaceuticals, Inc
$149
Upsher-Smith Laboratories LLC
$133
Kowa Pharmaceuticals America, Inc.
$128
Bayer Healthcare Pharmaceuticals Inc.
$109
AbbVie, Inc.
$97
Biohaven Pharmaceuticals, Inc.
$90
Esperion Therapeutics, Inc.
$90
Regeneron Healthcare Solutions, Inc.
$87
UPSHER-SMITH LABORATORIES LLC
$80
Amicus Therapeutics, Inc.
$75
Merck Sharp & Dohme Corporation
$67
Horizon Therapeutics plc
$67
Horizon Pharma plc
$65
Xeris Pharmaceuticals, Inc.
$63
Supernus Pharmaceuticals, Inc.
$56
Scilex Pharmaceuticals Inc.
$55
Nabriva Therapeutics, plc
$47
Antares Pharma, Inc.
$38
PORTOLA PHARMACEUTICALS, INC.
$36
MannKind Corporation
$33
TherapeuticsMD, Inc.
$32
RedHill Biopharma Inc.
$30
Medicure Pharma Inc.
$28
Tactile Systems Technology Inc
$27
DEXCOM, INC.
$25
Athena Bioscience, LLC
$20
Alfasigma USA, Inc.
$19
E.R. Squibb & Sons, L.L.C.
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
Exact Sciences Corporation
$16
Lundbeck LLC
$14
Azurity Pharmaceuticals, Inc.
$14
Purdue Pharma L.P.
$13
Top 3 companies account for 49.7% of total payments
Associated products mentioned in payments ›
AFREZZA · AIMOVIG · AIRSUPRA · ANDEXXA · Aemcolo · Aimovig · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BEVYXXA · BYDUREON · BYSTOLIC · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CREON · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · DUEXIS · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FABRAZYME · FARXIGA · FLEXITOUCH · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GALAFOLD · GVOKE HYPOPEN · Horizant · IMVEXXY · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LIVALO · LUCEMYRA · Livalo · MOUNJARO · MYRBETRIQ · Movantik · NEXLETOL · NEXLIZET · NOCDURNA · NURTEC ODT · Otezla · Ozempic · PENNSAID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 13 · Prolia · QDOLO · QULIPTA · RAYOS · RELISTOR · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMPROIC · Sivextro · TEFLARO · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TOVIAZ · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · Tresiba · Trintellix · Tymlos · UBRELVY · VIBERZI · VIMOVO · VRAYLAR · VYEPTI · Vascepa · Victoza · XARELTO · XIFAXAN · Xenleta · ZTLido · ZYPITAMAG · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (63%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for family medicine in TX.

Equivalent to $1,929 per 100 Medicare services performed
Looking for a family medicine in Lubbock?
Compare family medicines in the Lubbock area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
110
Per 100K population
35.0
County median income
$63,367
Nearest hospital
COVENANT MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ordonez is a clinical cardiology specialist, with above-average Medicare volume (top 29% in TX), and high industry engagement (low-engagement, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ordonez experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ordonez performed 603 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ordonez receive payments from pharmaceutical companies?
Yes. Dr. Ordonez received a total of $18,689 from 56 companies across 678 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ordonez's costs compare to other family medicines in Lubbock?
Dr. Ordonez's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ordonez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →